Heron Therapeutics, Inc. (HRTX)

NASDAQ: HRTX · Real-Time Price · USD

0.430

+0.020 (4.88%)

At close: Jun 26, 2026, 4:00 PM EDT

0.437

+0.007 (1.70%)

After-hours: Jun 26, 2026, 7:48 PM EDT

Heron Therapeutics Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Heron Therapeutics stock has a target of 2.00, which predicts an increase of 365.12% from the current stock price of 0.43.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$2.00	$2.00	$2.00	$2.00
Change	+365.12%	+365.12%	+365.12%	+365.12%

Analyst Ratings

The average analyst rating for Heron Therapeutics stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	3	2	2	2	2	2
Buy	1	1	1	1	1	0
Hold	0	0	0	0	0	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	3	3	3	3	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Brandon Folkes H.C. Wainwright	H.C. Wainwright	Buy Maintains $2	Buy	Maintains	$2	+365.12%	Jun 8, 2026
Serge Belanger Needham	Needham	Hold Downgrades n/a	Hold	Downgrades	n/a	n/a	Jun 2, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

165.65M

from 154.90M

6.94%

from 154.90M

Revenue Next Year

175.90M

from 165.65M

6.19%

from 165.65M

EPS This Year

-0.09

from -0.05

EPS Next Year

n/a

from -0.09

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	86.35M	107.67M	127.04M	144.29M	154.90M	165.65M	175.90M
Revenue Growth	-2.59%	24.70%	17.99%	13.57%	7.36%	6.94%	6.19%
EPS	-2.24	-1.67	-0.80	-0.09	-0.12	-0.07	-0.01
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	2	2

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	173.1M	198.5M
Avg	165.7M	175.9M
Low	158.2M	153.3M

Revenue Growth

Revenue Growth	2026	2027
High	11.7%	19.8%
Avg	6.9%	6.2%
Low	2.1%	-7.5%

EPS Forecast

EPS	2026	2027
High	-0.09	-
Avg	-0.09	-
Low	-0.09	-

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.